Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study.

Saved in:
Bibliographic Details
Title: Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study.
Authors: Stephan C; Department of Internal Medicine 2, Infectious Diseases Unit, University Hospital, Goethe University Frankfurt, Frankfurt, Germany., Spinner CD; TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, Munich, Germany., Rieke A; Gemeinschaftsklinikum Mittelrhein, Kemperhof, Koblenz, Germany., Christensen S; Center for Infectious Diseases (CIM), Münster, Germany.; Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Muenster, Münster, Germany., Mauss S; Center for HIV and Hepatogastroenterology, Dusseldorf, Germany., Schreiber S; Gilead Sciences GmbH, Martinsried, Germany., Albuquerque B; Gilead Sciences GmbH, Martinsried, Germany., Heinzkill M; Gilead Sciences GmbH, Martinsried, Germany., Ramroth H; Gilead Sciences Europe Ltd, Uxbridge, UK., Stellbrink HJ; ICH Study Center, Hamburg, Germany.
Source: HIV medicine [HIV Med] 2025 Feb; Vol. 26 (2), pp. 239-251. Date of Electronic Publication: 2024 Oct 30.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39476488
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stephan+C%22">Stephan C</searchLink>; Department of Internal Medicine 2, Infectious Diseases Unit, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Spinner+CD%22">Spinner CD</searchLink>; TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Rieke+A%22">Rieke A</searchLink>; Gemeinschaftsklinikum Mittelrhein, Kemperhof, Koblenz, Germany.<br /><searchLink fieldCode="AU" term="%22Christensen+S%22">Christensen S</searchLink>; Center for Infectious Diseases (CIM), Münster, Germany.; Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Muenster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Mauss+S%22">Mauss S</searchLink>; Center for HIV and Hepatogastroenterology, Dusseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Schreiber+S%22">Schreiber S</searchLink>; Gilead Sciences GmbH, Martinsried, Germany.<br /><searchLink fieldCode="AU" term="%22Albuquerque+B%22">Albuquerque B</searchLink>; Gilead Sciences GmbH, Martinsried, Germany.<br /><searchLink fieldCode="AU" term="%22Heinzkill+M%22">Heinzkill M</searchLink>; Gilead Sciences GmbH, Martinsried, Germany.<br /><searchLink fieldCode="AU" term="%22Ramroth+H%22">Ramroth H</searchLink>; Gilead Sciences Europe Ltd, Uxbridge, UK.<br /><searchLink fieldCode="AU" term="%22Stellbrink+HJ%22">Stellbrink HJ</searchLink>; ICH Study Center, Hamburg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100897392%22">HIV medicine</searchLink> [HIV Med] 2025 Feb; Vol. 26 (2), pp. 239-251. <i>Date of Electronic Publication: </i>2024 Oct 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100897392 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-1293 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214642662%22">14642662 </searchLink><i>NLM ISO Abbreviation: </i>HIV Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39476488
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/hiv.13728
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 239
    Titles:
      – TitleFull: Effectiveness, safety, and patient-reported outcomes of emtricitabine/tenofovir alafenamide-based regimens for the treatment of HIV-1 infection: Final 24-month results from the prospective German TAFNES cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stephan C
      – PersonEntity:
          Name:
            NameFull: Spinner CD
      – PersonEntity:
          Name:
            NameFull: Rieke A
      – PersonEntity:
          Name:
            NameFull: Christensen S
      – PersonEntity:
          Name:
            NameFull: Mauss S
      – PersonEntity:
          Name:
            NameFull: Schreiber S
      – PersonEntity:
          Name:
            NameFull: Albuquerque B
      – PersonEntity:
          Name:
            NameFull: Heinzkill M
      – PersonEntity:
          Name:
            NameFull: Ramroth H
      – PersonEntity:
          Name:
            NameFull: Stellbrink HJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1468-1293
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: HIV medicine
              Type: main
ResultId 1